Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anti-UAP1 Antibody (3Z178) is an antibody targeting UAP1. Anti-UAP1 Antibody (3Z178) can be used in ELISA,WB.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
50 μL | $208 | 7-10 days | |
100 μL | $348 | 7-10 days |
Description | Anti-UAP1 Antibody (3Z178) is an antibody targeting UAP1. Anti-UAP1 Antibody (3Z178) can be used in ELISA,WB. |
Ig Type | Rabbit IgG |
Clone | 3Z178 |
Reactivity | Human |
Verified Activity | Western Blot -Positive WB detected in: K562 whole cell lysate -All lanes: UAP1 antibody at 1:1000 -Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution -Predicted band size: 59, 58, 59 kDa -Observed band size: 59 kDa |
Application | |
Recommended Dose | WB:1:500-1:5000. |
Antibody Type | Monoclonal |
Subcellular Localization | Cytoplasm. Note=In spermatozoa, localized to the principal piece of the tail, the neck region of the head and to a lesser extent, the midpiece of the tail. |
Tissue Specificity | Widely expressed. Isoform AGX1 is more abundant in testis than isoform AGX2, while isoform AGX2 is more abundant than isoform AGX1 in somatic tissue. Expressed at low level in placenta, muscle and liver. |
Construction | Recombinant Antibody |
Purification | Affinity-chromatography |
Appearance | Liquid |
Formulation | Phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
Research Background | Converts UTP and GlcNAc-1-P into UDP-GlcNAc, and UTP and GalNAc-1-P into UDP-GalNAc. Isoform AGX1 has 2 to 3 times higher activity towards GalNAc-1-P, while isoform AGX2 has 8 times more activity towards GlcNAc-1-P. |
Conjucates | Unconjugated |
Immunogen | A synthetic peptide: Human UAP1 |
Antigen Species | Human |
Gene Name | UAP1 |
Gene ID | |
Uniprot ID | |
Biology Area | Metabolism, Signal transduction |
Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
Transport | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.